FR2705234B1 - Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA. - Google Patents

Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.

Info

Publication number
FR2705234B1
FR2705234B1 FR9306071A FR9306071A FR2705234B1 FR 2705234 B1 FR2705234 B1 FR 2705234B1 FR 9306071 A FR9306071 A FR 9306071A FR 9306071 A FR9306071 A FR 9306071A FR 2705234 B1 FR2705234 B1 FR 2705234B1
Authority
FR
France
Prior art keywords
autoantibodies
aids
diagnosis
treatment
human sera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9306071A
Other languages
English (en)
Other versions
FR2705234A1 (fr
Inventor
Geffard Michel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9306071A priority Critical patent/FR2705234B1/fr
Priority to PCT/FR1994/000597 priority patent/WO1994027151A1/fr
Publication of FR2705234A1 publication Critical patent/FR2705234A1/fr
Application granted granted Critical
Publication of FR2705234B1 publication Critical patent/FR2705234B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FR9306071A 1993-05-19 1993-05-19 Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA. Expired - Fee Related FR2705234B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9306071A FR2705234B1 (fr) 1993-05-19 1993-05-19 Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.
PCT/FR1994/000597 WO1994027151A1 (fr) 1993-05-19 1994-05-19 Utilisation de molecules reconnues par des autoanticorps de serums humains pour le diagnostic ou le traitement du sida

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9306071A FR2705234B1 (fr) 1993-05-19 1993-05-19 Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.

Publications (2)

Publication Number Publication Date
FR2705234A1 FR2705234A1 (fr) 1994-11-25
FR2705234B1 true FR2705234B1 (fr) 1995-08-04

Family

ID=9447309

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9306071A Expired - Fee Related FR2705234B1 (fr) 1993-05-19 1993-05-19 Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.

Country Status (2)

Country Link
FR (1) FR2705234B1 (fr)
WO (1) WO1994027151A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727117A1 (fr) * 1994-11-18 1996-05-24 Geffard Michel Utilisation de conjugues de la polylysine pour la preparation de medicaments utiles dans le traitement des maladies neurodegeneratives et des affections degeneratives a caractere autoimmun
AU2012241814A1 (en) * 2011-04-12 2013-10-03 Nestec S.A. Nutritional compositions including branched chain fatty acids for improving gut barrier function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681870A (en) * 1985-01-11 1987-07-21 Imre Corporation Protein A-silica immunoadsorbent and process for its production
AU2800389A (en) * 1987-12-02 1989-07-05 Regents Of The University Of California, The Aids-related anti-t-cell antibody test
EP0346091A3 (fr) * 1988-06-10 1990-09-12 Dana Farber Cancer Institute Procédé de diagnostic pour anticorps naturels contre cd4
WO1990008779A1 (fr) * 1989-01-31 1990-08-09 Idec Pharmaceuticals Corporation Anticorps anti-idiotypes reagissant avec des idiotopes partages exprimes par des lymphomes humains et des auto-anticorps
US5252556A (en) * 1990-03-30 1993-10-12 New England Medical Center Hospitals, Inc. Fragment capable of binding anti-CD43 autoantibodies
EP1314429A3 (fr) * 1990-05-21 2003-06-04 The Administrators Of The Tulane Educational Fund Utilisation d'un composé retrovirale dans la fabrication d'un médicament pour le traitement du sydrome de Sjögren, du lupus érythémateux disséminé, de la scléroderme, et de l'arthrite rheumatoide juvenile
US5230887A (en) * 1990-07-11 1993-07-27 Immune Network Research Ltd. Immune system stabilizers for prevention and therapy of disorders associated with immune system disfunction

Also Published As

Publication number Publication date
WO1994027151A1 (fr) 1994-11-24
FR2705234A1 (fr) 1994-11-25

Similar Documents

Publication Publication Date Title
FR2667944B1 (fr) Trousse et procede de diagnostic pour le diagnostic precoce des douleurs thoraciques.
DE3785409D1 (de) Vorrichtung zur untersuchung von ortsveraenderlichen medien mittels ultraschall-echographie.
DE69529307D1 (de) Ultraschall-Diagnose- und Behandlungssystem
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
DE595783T1 (de) System zur Ultraschallbehandlung.
FR2718037B1 (fr) Appareil de traitement de tumeur.
DE69015905T2 (de) Vorrichtung zur Behandlung von Flüssigkeiten.
FR2591116B1 (fr) Appareil de traitement par hyperthermie.
DE59600309D1 (de) Vorrichtung zur Behandlung von Flüssigkeiten, insbesondere von Blut
DE69333485D1 (de) Vorrichtung zur ausserkörperlichen blutbehandlung
FR2600521B1 (fr) Appareil de lithotritie ultrasonore.
DE69017799D1 (de) Ultraschall-Diagnosegerät.
FR2716363B1 (fr) Instrument de thérapie endoscopique.
FR2663044B1 (fr) Appareil pour le traitement de surfaces.
DE69310281T2 (de) Medizinisches Diagnosegerät zur Erkennung von Erkrankungen des Gehirns
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
DE69014771T2 (de) Ultraschall-Diagnosegerät.
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
FR2705234B1 (fr) Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.
DZ2012A1 (fr) Benzamides pour le traitement de dégénérescences neurologiques.
FR2600531B1 (fr) Appareil pour le traitement d'etats pathologiques par stimulation de points d'acupuncture.
FR2708191B1 (fr) Appareil de thérapie pour le traitement au moyen d'ondes acoustiques.
BE882635A (fr) Appareil d'hydrotherapie, en particulier pour le traitement des algies vertebrales
FR2718958B3 (fr) Dispositif pour le traitement du corps humain.
IL85358A (en) Optimal parametric signal processor for least squares finite impulse response filtering

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090119